Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3.
Saved in:
| Title: | Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3. |
|---|---|
| Authors: | Darwesh AM; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1., Fang L; Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, 7-55 Medical Sciences Building, Edmonton, AB, Canada T6G 2H7., Altamimi TR; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada., Jamieson KL; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1., Bassiouni W; Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, 7-55 Medical Sciences Building, Edmonton, AB, Canada T6G 2H7., Valencia R; Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, 7-55 Medical Sciences Building, Edmonton, AB, Canada T6G 2H7., Huang A; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1., Wang F; Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Zhang H; Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada., Ahmed M; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1.; Quantitative Solutions, API, Edmonton, AB, Canada., Gopal K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1., Zhang Y; Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada., Michelakis ED; Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada., Ussher JR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1., Edin ML; National Institute of Environmental Health Sciences, NIH, Research Triangle Park, Durham, NC, USA., Zeldin DC; National Institute of Environmental Health Sciences, NIH, Research Triangle Park, Durham, NC, USA., Barakat K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1.; Li Ka Shing Applied Virology Institute, University of Alberta, Edmonton, AB, Canada., Oudit GY; Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada., Kassiri Z; Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Lopaschuk GD; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada., Seubert JM; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35 Medical Sciences Building, Edmonton, AB, Canada T6G 2H1.; Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, 7-55 Medical Sciences Building, Edmonton, AB, Canada T6G 2H7. |
| Source: | Cardiovascular research [Cardiovasc Res] 2025 Apr 22; Vol. 121 (2), pp. 267-282. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1755-3245 |
|---|---|
| DOI: | 10.1093/cvr/cvae252 |
